FDA warns anesthesiologist for running clinical investigations without an IND
Maggie Jeffries, owner of Houston-based Avanti Anesthesia, has run afoul of the FDA’s rules on clinical investigations, according to a warning letter released today, with the agency noting that the combo of drugs she used put some surgery patients at increased risks.
The letter pertains to two clinical investigations: one of which Jeffries served as sponsor-investigator for a trial with cataract surgery patients, and the other she performed for the drug compounder Imprimis Pharmaceuticals.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,900+ biopharma pros reading Endpoints daily — and it's free.